As of 31 May 2026, 1 Indian mutual fund hold Q-Line Biotech Limited (Healthcare), led by Abakkus Small Cap Fund at 1.72% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.
As of 31 May 2026, 1 Indian mutual fund schemes disclose a holding in Q-Line Biotech Limited (Healthcare). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.
Across the 1 fund holding Q-Line Biotech Limited, the average position size is 1.72% of net assets. The highest-conviction holder is Abakkus Small Cap Fund (Equity), at 1.72%. Over the last month, 1 fund initiated a new position and 0 funds exited.
How funds changed their Q-Line Biotech Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| # | Fund | AMC | Category | % to NAV |
|---|---|---|---|---|
| 1 | Abakkus Small Cap Fund | Abakkus Mutual Fund | Equity | 1.72% |
Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.
Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.